Asia-Pacific Artificial Tear Market
Asia-Pacific Artificial Tear Market Size, Share & Trends Analysis Report by Type (Cellulose-Derived Tears, Glycerin-Derived Tears, Oil-Based Emulsion Tears, and Polyethylene Glycol- & Propylene Glycol-Based Tears), By Delivery Method (Eyedrops and Ointments/Gel), By Application (Dry Type Treatment, Contact Lens Moisture, and Digital Eye Strain) and By End-User (Retail Pharmacies (OTC), Online Pharmacies, Hospitals & Ophthalmic Clinics, and Other End User) Forecast Period, (2026-2035)
Industry Overview
Asia-Pacific artificial tear market was valued at $906.9 million in 2025 and is projected to reach $1,639.5 million by 2035, growing at a CAGR of 6.2% during the forecast period (2026–2035). The Asia-Pacific artificial tear market is witnessing robust growth as ophthalmology clinics, hospitals, and retail pharmacies increasingly prioritize the management of dry eye disease and other ocular surface disorders. Market expansion is being fueled by the rising prevalence of myopia, digital eye strain, and age-related ocular conditions, coupled with growing awareness of eye health among urban populations. Adoption is further supported by increasing disposable incomes, expanding healthcare infrastructure, and government initiatives promoting vision care across the region. The market is also benefiting from continuous product innovation, including cellulose-derived formulations, preservative-free options, and advanced multipurpose eye drops that offer enhanced hydration, longer retention, and improved patient comfort.
Market Dynamics
Rising Demand Driven by Growing Prevalence of Ocular Disorders
Increasing incidence of dry eye disease, myopia, digital eye strain, and age-related ocular conditions across Asia-Pacific is fueling demand for artificial tear products. Countries such as China, Japan, India, and South Korea are witnessing rising patient awareness and healthcare accessibility, prompting ophthalmology clinics, hospitals, and retail pharmacies to expand their product offerings. The growing emphasis on eye health and preventive care is reinforcing steady market growth across the region.
Technological Advancements in Formulations and Delivery Systems
Manufacturers in Asia-Pacific are introducing advanced artificial tear formulations, including cellulose-derived, preservative-free, and multipurpose eye drops, to enhance efficacy, patient comfort, and compliance. Emerging delivery technologies, such as sustained-release formulations and single-use dispensers, are improving convenience and safety. Continuous innovation, combined with increasing collaborations between regional pharmaceutical companies and research institutions, is driving product differentiation and strengthening market competitiveness.
Market Segmentation
- Based on type, the market is segmented into glycerin?derived tears, cellulose?derived tears, oil?based / emulsion?based tears, polyethylene glycol (PEG)-based tears, propylene glycol-based tears, and hyaluronic acid.
- Based on the delivery mode, the market is segmented into eye drops and ointments.
- Based on the application, the market is segmented into dry eye syndrome, digital eye strain, and contact lens discomfort/moisture retention.
- Based on the end user, the market is segmented into retail pharmacies (OTC), online pharmacies, hospitals & ophthalmic clinics, and others.
Preservative-Free Drops Segment to Lead the Market with the Largest Share
In the Asia-Pacific artificial tear market, the preservative-free drops segment is expected to hold the largest share within the type category. This dominance is driven by growing clinical preference for safer, non-irritating formulations, particularly among patients requiring frequent or long-term management of dry eye disease. Concerns over preservative-induced ocular surface damage, including effects from benzalkonium chloride (BAK), have accelerated the shift toward preservative-free products across countries such as China, Japan, India, and South Korea. Rising prevalence of dry eye—fueled by aging populations, increasing digital device usage, contact lens adoption, and expanding ophthalmic surgical procedures—further reinforces demand for preservative-free artificial tears. Ophthalmologists and optometrists across the region increasingly recommend these formulations to minimize inflammation, support tear film restoration, and improve patient comfort.
Eye Drops: Key Segment Driving Market Growth Across Asia-Pacific
Among all product formats in the Asia-Pacific artificial tear market, eye drops continue to be the most dominant and fastest-growing delivery mode, driving regional market expansion. Their convenience, rapid symptom relief, and strong consumer familiarity make eye drops the preferred first-line therapy for mild to moderate dry eye symptoms. Factors such as prolonged screen exposure, urban air pollution, air-conditioned indoor environments, and growing contact lens usage have significantly increased daily reliance on eye drops for quick ocular hydration. Eye-care professionals consistently recommend drops due to ease of self-administration, widespread OTC availability, and suitability for multiple daily applications, supporting high repeat usage and sustained demand. Consequently, eye drops remain central to dry eye management and play a critical role in shaping the growth trajectory of the Asia-Pacific artificial tear market.
Regional Outlook
Asia-Pacific artificial tear market is further divided by countries, including China, Japan, South Korea, India, Australia & New Zealand, ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, and others), and the Rest of Asia-Pacific.
China Dominates the Market with Major Share
China is leading the Asia-Pacific artificial tear market, driven by rising prevalence of dry eye disease, increasing digital device usage, and growing awareness of eye health among urban populations. The country’s expanding healthcare infrastructure, coupled with government initiatives promoting vision care and ophthalmic services, is boosting accessibility and consumption of artificial tear products. Local manufacturers are increasingly introducing advanced formulations, including preservative-free, cellulose-derived, and multipurpose eye drops, to meet diverse patient needs. As demand rises for both over-the-counter and clinically recommended therapies, China continues to maintain a dominant market position, reinforcing its status as a key growth hub within the Asia-Pacific region.
Market Players Outlook
The major companies operating in the Asia-Pacific artificial tear market include AbbVie Inc., Alcon Inc., Bausch +?Lomb Corporation, Johnson & Johnson Vision Care, Santen Pharmaceutical Co., Ltd., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In January 2025, Santen Pharmaceutical (China) launched a new preservative-free artificial tear formulation targeting patients with moderate to severe dry eye. The product rollout underscores growing demand for safer, irritation-free therapies and strengthens the company’s presence in major ophthalmology clinics across China.
- In April 2024, Allergan (Ireland, with strong APAC operations) expanded its Asia-Pacific footprint by introducing advanced cellulose-derived and multipurpose eye drops in India, South Korea, and Japan. The move reflects rising adoption of innovative formulations tailored to regional ocular health needs.
- In October 2024, Rohto Pharmaceutical (Japan) unveiled a new single-use, fast-acting artificial tear product with enhanced hydration technology, aimed at digital-device users. This development highlights ongoing innovation in delivery formats and patient-centric design within the APAC market.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the Asia-Pacific artificial tear Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Asia-Pacific Artificial Tear Market Sales Analysis – Type | Delivery Method | Application | End-User ($ Million)
- Artificial Tear Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Asia-Pacific Artificial Tear Industry Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers For Asia-Pacific Artificial Tear Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Asia-Pacific Artificial Tear Market: Impact Analysis
- Market Opportunities
- Opportunities For Asia-Pacific Artificial Tear Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Asia-Pacific Artificial Tear Market Revenue and Share by Manufacturers
- Artificial Tear Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- AbbVie Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Alcon Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Bausch +?Lomb Corporation
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Johnson & Johnson Vision Care
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Santen Pharmaceutical Co., Ltd.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- AbbVie Inc.
- Key Company Analysis
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Asia-Pacific Artificial Tear Market Sales Analysis By Type ($ Million)
- Cellulose-Derived Tears
- Glycerin-Derived Tears
- Oil-Based Emulsion Tears
- Polyethylene Glycol- & Propylene Glycol-Based Tears
- Asia-Pacific Artificial Tear Market Sales Analysis By Delivery Method ($ Million)
- Eyedrops
- Ointments/Gel
- Asia-Pacific Artificial Tear Market Sales Analysis By Application ($ Million)
- Dry Type Treatment
- Contact Lens Moisture
- Digital Eye Strain
- Asia-Pacific Artificial Tear Market Sales Analysis By End-User ($ Million)
- Retail Pharmacies (OTC)
- Online Pharmacies
- Hospitals & Ophthalmic Clinics
- Other End User
- Regional Analysis
- Asia-Pacific Artificial Tear Market Sales Analysis – Type | Delivery Method | Application | End-User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And others)
- Rest of Asia-Pacific
- Company Profiles
- Abbott Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- AbbVie Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Alcon Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Aurolab
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bausch & Lomb Incorporated
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bayer AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Jiangxi Zhenshiming Pharmaceutical Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Johnson & Johnson Vision Care
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nicox S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- OASIS Medical
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- OCuSOFT Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Prestige Consumer Healthcare Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Rohto Pharmaceutical Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Santen Pharmaceutical Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sentiss Pharma Pvt. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Similasan Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sintong Pharmaceutical
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sun Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ursapharm Arzneimittel GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Wuhan Yuanda Pharmaceuticals Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories
1. Asia-Pacific Artificial Tear Market Research and Analysis by Type, 2025–2035 ($ Million)
2. Asia-Pacific Cellulose-Derived Tears Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Asia-Pacific Glycerin-Derived Tears Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Asia-Pacific Oil-Based Emulsion Tears Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Asia-Pacific Polyethylene Glycol- & Propylene Glycol-Based Tears Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Asia-Pacific Artificial Tear Market Research and Analysis by Delivery Method, 2025–2035 ($ Million)
7. Asia-Pacific Artificial Tear Eye Drops Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Asia-Pacific Artificial Tear Ointments Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Asia-Pacific Artificial Tear Market Research and Analysis by Application, 2025–2035 ($ Million)
10. Asia-Pacific Artificial Tear In Dry Eye Syndrome Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Asia-Pacific Artificial Tear In Digital Eye Strain Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Asia-Pacific Artificial Tear In Contact Lens Discomfort / Moisture Retention Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Asia-Pacific Artificial Tear Market Research and Analysis by End-User, 2025–2035 ($ Million)
14. Asia-Pacific Artificial Tear For Retail Pharmacies (OTC) Market Research And Analysis By Region, 2025–2035 ($ Million)
15. Asia-Pacific Artificial Tear For Online Pharmacies Market Research And Analysis By Region, 2025–2035 ($ Million)
16. Asia-Pacific Artificial Tear For Hospitals & Ophthalmic Clinics Market Research And Analysis By Region, 2025–2035 ($ Million)
17. Asia-Pacific Artificial Tear For Other End User Market Research And Analysis By Region, 2025–2035 ($ Million)
18. Asia-Pacific Artificial Tear Market Research And Analysis By Region, 2025-2035 ($ Million)
19. Asia-Pacific Artificial Tear Market Research and Analysis by Type, 2025–2035 ($ Million)
20. Asia-Pacific Artificial Tear Market Research and Analysis by Delivery Method, 2025–2035 ($ Million)
21. Asia-Pacific Artificial Tear Market Research and Analysis by Application, 2025–2035 ($ Million)
22. Asia-Pacific Artificial Tear Market Research and Analysis by End-User, 2025–2035 ($ Million)
1. Asia-Pacific Artificial Tear Market Share By Type, 2025 Vs 2035 (%)
2. Asia-Pacific Cellulose-Derived Tears Market Share By Region, 2025 Vs 2035 (%)
3. Asia-Pacific Glycerin-Derived Tears Market Share By Region, 2025 Vs 2035 (%)
4. Asia-Pacific Oil-Based Emulsion Tears Market Share By Region, 2025 Vs 2035 (%)
5. Asia-Pacific Polyethylene Glycol- & Propylene Glycol-Based Tears Market Share By Region, 2025 Vs 2035 (%)
6. Asia-Pacific Artificial Tear Market Share By Delivery Method, 2025 Vs 2035 (%)
7. Asia-Pacific Eye Drops Artificial Tear Market Share By Region, 2025 Vs 2035 (%)
8. Asia-Pacific Ointments Artificial Tear Market Share By Region, 2025 Vs 2035 (%)
9. Asia-Pacific Artificial Tear Market Share By Application, 2025 Vs 2035 (%)
10. Asia-Pacific Artificial Tear In Dry Eye Syndrome Market Share By Region, 2025 Vs 2035 (%)
11. Asia-Pacific Artificial Tear In Digital Eye Strain Market Share By Region, 2025 Vs 2035 (%)
12. Asia-Pacific Artificial Tear In Contact Lens Discomfort / Moisture Retention Market Share By Region, 2025 Vs 2035 (%)
13. Asia-Pacific Artificial Tear Market Share By End-User, 2025 Vs 2035 (%)
14. Asia-Pacific Artificial Tear For Retail Pharmacies (OTC) Market Share By Region, 2025 Vs 2035 (%)
15. Asia-Pacific Artificial Tear For Online Pharmacies Market Share By Region, 2025 Vs 2035 (%)
16. Asia-Pacific Artificial Tear For Hospitals & Ophthalmic Clinics Market Share By Region, 2025 Vs 2035 (%)
17. Asia-Pacific Artificial Tear For Other End User Market Share By Region, 2025 Vs 2035 (%)
18. Asia-Pacific Artificial Tear Market Share by Region, 2024 Vs 2035 (%)
19. China Artificial Tear Market Size, 2025–2035 ($ Million)
20. Japan Artificial Tear Market Size, 2025–2035 ($ Million)
21. South Korea Artificial Tear Market Size, 2025–2035 ($ Million)
22. India Artificial Tear Market Size, 2025–2035 ($ Million)
23. Australia & New Zealand Artificial Tear Market Size, 2025–2035 ($ Million)
24. ASEAN Countries Artificial Tear Market Size, 2025–2035 ($ Million)
25. Rest of Asia-Pacific Artificial Tear Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Asia-Pacific Air Taxi Market in 2025 is estimated to be around $906.9 million.
China holds the largest share in the Asia-Pacific Air Taxi Market.
Leading players in the Asia-Pacific Air Taxi Market include AbbVie Inc., Alcon Inc., Bausch + Lomb Corporation, Johnson & Johnson Vision Care, Santen Pharmaceutical Co., Ltd., among others.
Asia-Pacific Air Taxi Market is expected to grow at a CAGR of 6.2% from 2026 to 2035.
The Asia-Pacific Air Taxi Market is growing due to rapid urbanization and traffic congestion in major cities, rising disposable incomes, strong government support and investments in infrastructure and smart city initiatives, and advances in eVTOL and urba
